Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes
Open Access
- 1 September 2003
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 84 (9) , 2409-2421
- https://doi.org/10.1099/vir.0.19152-0
Abstract
MHC-I-restricted cytotoxic responses are considered a critical component of protective immunity against viruses, including human immunodeficiency virus type 1 (HIV-1). CTLs directed against accessory and early regulatory HIV-1 proteins might be particularly effective; however, CTL epitopes in these proteins are rarely found. Novel artificial neural networks (ANNs) were used to quantitatively predict HLA-A2-binding CTL epitope peptides from publicly available full-length HIV-1 protein sequences. Epitopes were selected based on their novelty, predicted HLA-A2-binding affinity and conservation among HIV-1 strains. HLA-A2 binding was validated experimentally and binders were tested for their ability to induce CTL and IFN-γ responses. About 69 % were immunogenic in HLA-A2 transgenic mice and 61 % were recognized by CD8+ T-cells from 17 HLA-A2 HIV-1-positive patients. Thus, 31 novel conserved CTL epitopes were identified in eight HIV-1 proteins, including the first HLA-A2 minimal epitopes ever reported in the accessory and regulatory proteins Vif, Vpu and Rev. Interestingly, intermediate-binding peptides of low or no immunogenicity (i.e. subdominant epitopes) were found to be antigenic and more conserved. Such epitope peptides were anchor-optimized to improve immunogenicity and further increase the number of potential vaccine epitopes. About 67 % of anchor-optimized vaccine epitopes induced immune responses against the corresponding non-immunogenic naturally occurring epitopes. This study demonstrates the potency of ANNs for identifying putative virus CTL epitopes, and the new HIV-1 CTL epitopes identified should have significant implications for HIV-1 vaccine development. As a novel vaccine approach, it is proposed to increase the coverage of HIV variants by including multiple anchor-optimized variants of the more conserved subdominant epitopes.Keywords
This publication has 50 references indexed in Scilit:
- Prior Vaccination Increases the Epitopic Breadth of the Cytotoxic T-Lymphocyte Response That Evolves in Rhesus Monkeys following a Simian-Human Immunodeficiency Virus InfectionJournal of Virology, 2002
- Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+T-Cell Populations with Differing Cytolytic ActivitiesJournal of Virology, 2001
- Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding MotifJournal of Virology, 2001
- Letter to the Editor: Who Is Right? Or, How to Judge the Disagreement about HLA Restriction of Nef PeptidesAIDS Research and Human Retroviruses, 1998
- Two complementary methods for predicting peptides binding major histocompatibility complex moleculesJournal of Molecular Biology, 1997
- Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of bindingEuropean Journal of Immunology, 1996
- Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic miceEuropean Journal of Immunology, 1996
- Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumorsEuropean Journal of Immunology, 1995
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Expression and function of HLA‐A2.1 in transgenic miceEuropean Journal of Immunology, 1989